Table 3 Univariate and multivariate linear regression analysis of FNA-Tg influences.

From: FNA-Tg improves the diagnostic efficacy of FNAC for PTC lateral cervical LN metastasis

 

FNA-Tg(ng/mL)

Univariate Linear Regression Analysis

FNA-Tg(ng/mL)

Multivariate Linear Regression Analysis

β(95%CI)

P

β(95%CI)

P

Gender

 Male

1

0.18

  

 Female

-32.74(-80.94-15.45)

Age (years)

-1.13(-3.07-0.80)

0.25

  

Definite lymph node status

 Without Metastasis

1

< 0.01

247.65(206.19-289.11)

< 0.01

 With Metastasis

250.09(209.69–290.50)

 Serum Tg(ng/mL)

0.20(-0.06-0.46)

0.12

  

 TSH(uIU/ml)

0.59(-0.88-2.05)

0.43

  

 Serum TgAb(IU/mL)

-0.06(-0.14-0.02)

0.13

  

Total Thyroidectomy

 Not Performed(

1

0.09

30.44(-26.74-87.62)

0.30

 Performed

56.12(-9.54-121.77)

 Lymph Node Short-Axis Size(mm)

6.33(0.46–12.19)

0.03

0.23(-4.93-5.39)

0.93

  1. FNA-Tg: thyroglobulin in lymph node fine needle aspirates; TSH: thyroid stimulating hormone; TgAb: thyroglobulin antibody.